In a filing, MAIA Biotechnology Inc revealed its Director Smith Stan acquired Company’s shares for reported $0.2 million on Mar 14 ’24. In the deal valued at $1.17 per share,170,940 shares were bought. As a result of this transaction, Smith Stan now holds 857,568 shares worth roughly $2.11 million.
Then, Louie Ngar Yee bought 170,940 shares, generating $200,000 in total proceeds. Upon buying the shares at $1.17, the Director now owns 1,147,524 shares.
Before that, Luput Cristian bought 69,282 shares. MAIA Biotechnology Inc shares valued at $81,060 were divested by the Director at a price of $1.17 per share. As a result of the transaction, Luput Cristian now holds 367,350 shares, worth roughly $0.9 million.
Price Performance Review of MAIA
On Tuesday, MAIA Biotechnology Inc [AMEX:MAIA] saw its stock jump 8.85% to $2.46. Over the last five days, the stock has gained 19.42%. MAIA Biotechnology Inc shares have risen nearly 110.26% since the year began. Nevertheless, the stocks have fallen -16.61% over the past one year. While a 52-week high of $3.24 was reached on 03/25/24, a 52-week low of $0.82 was recorded on 01/16/24. SMA at 50 days reached $1.83, while 200 days put it at $1.74. A total of 0.24 million shares were traded, compared to the trading of 0.11 million shares in the previous session.
Levels Of Support And Resistance For MAIA Stock
The 24-hour chart illustrates a support level at 2.25, which if violated will result in even more drops to 2.03. On the upside, there is a resistance level at 2.59. A further resistance level may holdings at 2.71. The Relative Strength Index (RSI) on the 14-day chart is 61.27, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.03, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 20.81%. Stochastics %K at 56.60% indicates the stock is a holding.
